Arrowhead Pharmaceuticals
ARWRArrowhead Pharmaceuticals is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead’s products in development act through RNA interference (RNAi) mechanisms of action. The company focuses on treatments for Hepatitis B, the liver disease associated with alpha 1-antitryps …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at Arrowhead Pharmaceuticals
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 4/11/2025 | Sell | Anzalone, Christopher Richard | Chief Executive Officer | $11.5 | $583,692 |
| 4/10/2025 | Sell | Anzalone, Christopher Richard | Chief Executive Officer | $10.9 | $543,500 |
| 4/9/2025 | Sell | Anzalone, Christopher Richard | Chief Executive Officer | $10.8 | $406,145 |
| 3/13/2025 | Sell | Anzalone, Christopher Richard | Chief Executive Officer | $15.1 | $774,975 |
| 3/4/2025 | Sell | Anzalone, Christopher Richard | Chief Executive Officer | $17.0 | $2,269,328 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)